Skip to content

Medical and Surgical Hybrid Treatment of Atrial Fibrillation.

Medical and Surgical Hybrid Treatment of Atrial Fibrillation: Epicardial and Endocardial Combined Approach.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02630914
Acronym
HT2AF
Enrollment
12
Registered
2015-12-15
Start date
2015-09-30
Completion date
2018-03-31
Last updated
2025-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrial Fibrillation (AF)

Keywords

Epicardial surgical removal, Closure of the left atrial, Left atrial appendage (LAA)

Brief summary

The objective of the study is to investigate the feasibility of a hybrid procedure removal of the atrial fibrillation. This is a single procedure for both surgical epicardial by minimally invasive route (Thoracoscopy) without even flow controlled and supplemented if necessary by extra corporeal intracavitary route at the same time. This faster procedure combined with complete lesions have a higher success rate and less frequent re-hospitalizations of patients.

Interventions

DEVICEThe AtriCure Synergy Ablation System

The AtriCure Synergy Ablation System will be used on all patients for AF ablation.

Sponsors

University Hospital, Toulouse
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

patients with complex AF defined by the following criteria : * AF\> 1 week or long term persistent\> 1 year * AND Symptomatic * AND after failure of treatment of anti-arrhythmic or against-indication for anti-arrhythmic

Exclusion criteria

The

Design outcomes

Primary

MeasureTime frameDescription
Number of participants with complete procedure or not3 hoursAt the end of the intervention, the doctor evaluates whether the procedure was complete with electric exclusion of the posterior wall of the left atrium and the 4 pulmonary veins.

Secondary

MeasureTime frameDescription
Number of atrial fibrillation episode12 months
Stroke Rate12 months
Hospitalization for heart failure12 monthsThe number of hospitalizations for heart failure after hybrid procedure
Evaluation of Quality of life (EQ-5D according to the survey-3L)12 monthsThe quality of life will be measured using the EQ-5D 3L questionnaire (EQ-5D according to the survey-3L)
The cost-effectiveness ration12 monthsCost estimates will be conducted from the perspective of health insurance. The expenses incurred in the care of patients will be counted during the follow-up year. The effectiveness will be assessed against the complications of strategy

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026